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Abstract: 
Introduction: Hodgkin lymphoma (HL), formerly called Hodgkin's disease, arises from germinal center or post-
germinal center B cells. HL has a unique cellular composition, containing a minority of neoplastic cells (Reed-
Sternberg cells and their variants) in an inflammatory background. Aims and objectives: The main objective of the 
study is to analyze the clinico pathological features of classic and non-classic Hodgkin lymphoma in Pakistan. 
Material and methods: This study was conducted in Jinnah hospital, Lahore and Nishtar Hospital Multan during 
2018 with the permission of ethical committee of hospital. This was basically a case study which was seen in Jinnah 
Hospital Lahore. There was a female in her 60s who presented with cervical lymphadenopathy associated with heavy 
infection with Epstein-Barr virus (EBV), diagnosed as Hodgkin lymphoma, mixed cellularity. During the staging 
workup, the patient was discovered to have extensive bone marrow (BM) involvement by Burkitt leukemia/lymphoma 
(BL). A diagnosis of concomitant EBV-related discordant lymphoma (cHL and BL) in leukemic phase was made. 
Results: Histopathological examination of the LN revealed subtotal effacement of the nodal tissue by a diffuse 
proliferation of lymphoid cells intermixed with scattered histiocytes, plasma cells, and eosinophils. There were many 
large atypical cells consistent with Hodgkin/Reed–Sternberg cells and mummified cells seen in the reactive 
background. As the patient’s general condition had rapidly deteriorated and as a part of staging workup for HL, BM 
examination was performed. The BM aspirate smear unexpectedly showed infiltration with monotonous population of 
leukemic cells (~27%), medium size with regular round nuclei, dispersed nuclear chromatin, deeply basophilic 
cytoplasm with prominent vacuolation. Conclusion: It is concluded that correct diagnosis and appropriate treatment 
for composite CHL and B-NHL is highly important in patient’s ≥40 years old. CHL must continue to be recognized 
because the disease subsets may have variable natural histories, prognosis, and different treatment modalities.  
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INTRODUCTION: 
Hodgkin lymphoma (HL), formerly called Hodgkin's 
disease, arises from germinal center or post-germinal 
center B cells. HL has a unique cellular composition, 
containing a minority of neoplastic cells (Reed-
Sternberg cells and their variants) in an inflammatory 
background. It is separated from the other B cell 
lymphomas based on its unique clinic-pathologic 
features, and can be divided into two major subgroups, 
based on the appearance and immuno phenotype of the 
tumor cells [1]. 
Of all Hodgkin lymphomas (HL), classical Hodgkin 
lymphoma (CHL) accounts for ∼95% of all cases, 
whereas the remaining 5% comprises nodular 
lymphocyte predominant Hodgkin lymphoma. CHL 
shows a peak incidence at 15–35 years, and a second 
peak in elderly patients. Epstein–Barr virus (EBV) has 
been postulated to play a role in the pathogenesis and 
the outcome of CHL [2]. The reported incidence of 
EBV positivity in CHL cases varies: 31% (≥50 years 
old) (3) and 34% (≥60 years old) in two European 
studies, but up to 100% in tropical regions. In 
particular, EBV is frequently found in mixed 
cellularity and lymphocyte depleted subtypes [3]. The 
prognostic significance of EBV-association on OS in 
CHL cases is controversial. However, there have been 
several reports suggesting unfavorable OS in elderly 
patients with EBV-positive CHL compared with that 
of patients with EBV-negative CHL [4]. Hodgkin's 
lymphoma (HL) is a lymphoid tumor representing less 
than 1% of all de novo neoplasms occurring every year 
worldwide. Its diagnosis is based on the identification 
of characteristic multinucleated giant cells within an 
inflammatory milieu. These cells termed Reed-
Sternberg (RS) or diagnostic cells represent the body 
of the tumor; they measure 20–60 μm in diameter and 
display a large rim of cytoplasm and at least two nuclei 
with acidophilic or amphophilic nucleoli, covering 
more than 50% of the nuclear area [5]. 
The tumoral population also includes a variable 
number of mononuclear elements, Hodgkin's cells 
(HCs) showing similar cytological features to RS cells 
and neoplastic cell variants, each corresponding to a 
specific subtype of HL. Molecular studies have only 
recently shown that in most if not all cases RS cells, 
Hodgkin's cells, and cell variants belong to the same 
clonal population, which is derived from peripheral B 
cell [6]. 
Aims and objectives 
The main objective of the study is to analyze the 
clinico pathological features of classic and non-classic 
Hodgkin lymphoma in Pakistan. 
 
MATERIAL AND METHODS: 
This study was conducted in Jinnah hospital, Lahore 
and Nishtar Hospital Multan during 2018 with the 
permission of ethical committee of hospital. This was 
basically a case study which was seen in Jinnah 
Hospital Lahore. There was a female in her 60s who 
presented with cervical lymphadenopathy associated 
with heavy infection with Epstein-Barr virus (EBV), 
diagnosed as Hodgkin lymphoma, mixed cellularity. 
During the staging workup, the patient was discovered 
to have extensive bone marrow (BM) involvement by 
Burkitt leukemia/lymphoma (BL). A diagnosis of 
concomitant EBV-related discordant lymphoma (cHL 
and BL) in leukemic phase was made. 
She presented with a seven-month history of right-
sided neck swelling, weight loss, and night sweating. 
On initial physical examination, the patient had 
hepatosplenomegaly and right cervical 
lymphadenopathy for which an excisional lymph node 
(LN) biopsy was performed and a diagnosis of 
Hodgkin lymphoma, mixed cellularity type III, was 
confirmed. 
RESULTS: 
Histopathological examination of the LN revealed 
subtotal effacement of the nodal tissue by a diffuse 
proliferation of lymphoid cells intermixed with 
scattered histiocytes, plasma cells, and eosinophils. 
There were many large atypical cells consistent with 
Hodgkin/Reed–Sternberg cells and mummified cells 
seen in the reactive background. As the patient’s 
general condition had rapidly deteriorated and as a part 
of staging workup for HL, BM examination was 
performed. The BM aspirate smear unexpectedly 
showed infiltration with monotonous population of 
leukemic cells (~27%), medium size with regular 
round nuclei, dispersed nuclear chromatin, deeply 
basophilic cytoplasm with prominent vacuolation. 
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Figure 1: Histological examination. (A & B) Hodgkin/Reed-Sternberg cells seen in a reactive background of a lymph 
node tissue (H&E ×40). (C & D) Immunohistochemical study demonstrates that Reed-Sternberg cells are positive for 
CD30 and CD15. (E) Reed-Sternberg cells are positive for EBV (LMP-1). 
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Figure 02: The reactive “milieau” in Hodgkin lymphoma. Mast cells and regulatory T cells populate the HL 
microenvironment showing spatial interaction with RS cells. 
 
DISCUSSION: 
Most of clinically reported CLs are actually sequential 
lymphomas in which two different histological types 
of lymphoma occur in the same group of LNs after 
successful treatment of the first lymphoma. In these 
instances, the development of the second lymphoma 
might have been a coincidental occurrence or 
secondary to cytotoxic therapy received for treatment 
of the first lymphoma [7]. Discordant lymphoma is 
another rare condition in which different types of 
malignant lymphomas occur in different anatomic 
sites. The two diseases may present clinically as 
concurrent or sequential disease [8]. 
The concept of CL was first proposed by Custer to 
denote the occurrence of more than one histological 
type of lymphoma in a single patient. The concept of 
CL is now restricted by some authors to the rare 
occurrence of two or more morphologically and 
immunophenotypically distinct lymphoma clones in a 
single anatomical site, ie, within a single organ or 
tissue [9]. 
In most instances (11 of 18 informative cases), the 
cHL and the NHL were clonally related. The reported 
NHL that was found to be clonally related to cHL 
included follicular lymphoma, mantle cell lymphoma, 
diffuse large cell lymphoma, and chronic lymphocytic 
leukemia [10]. In eight of 18 combinations of a HL and 
a NHL that were diagnosed consecutively, the 
lymphomas were clonally unrelated [11]. Inspite of the 
relatively long history of LN enlargement, the 
possibility that BL could represent a transformation of 
HL is very remote, since cHL does not have a tendency 
to transform into more aggressive subtypes unlike 
NLPHL, which has a tendency to transform into a 
high-grade lymphoma [12]. 
CONCLUSION: 
It is concluded that correct diagnosis and appropriate 
treatment for composite CHL and B-NHL is highly 
important in patient’s ≥40 years old. CHL must 
continue to be recognized because the disease subsets 
may have variable natural histories, prognosis, and 
different treatment modalities.  
 
REFERENCES: 
1. Kerl K, Girardet C, Borisch B. A common B-cell 
precursor in composite lymphomas. N Engl J 
Med. 1999;341:764–765. 
2. Yoshinaga H, Ohashi K, Yamamoto K, et al. 
Clonal identification of Burkitt’s lymphoma 
arising from lymphocyte-predominant Hodgkin’s 
disease. Br J Haematol. 1996;95(2):380–382.  
3. Kotila TR, Aken’ova YA, Shokunbi WA, 
Akingbola TS, Fasola FA. Hodgkin’s disease 
after treatment for Burkitt’s lymphoma: case 
report. East Afr Med J. 2001;78:6.  
4. Chapman A, Rickinson A. Epstein-Barr virus in 
Hodgkin’s disease. Ann Oncol. 1998;9:S5–S16. 
IAJPS 2019, 06 (02), 4542-4546        Muhammad Ali Hassan Khan et al         ISSN 2349-7750 
 
 
w w w . i a j p s . c o m  
 
Page 4546 
5. Jarrett R, Gallagher A, Jones D, et al. Detection of 
EBV genomes in Hodgkin’s disease: relation to 
age. J Clin Pathol (Lond) 1991;44:844–848.  
6. Razzouk B, Gan Y, Mendonca C, et al. Epstein-
Barr virus in pediatric Hodgkin’s disease: age and 
histiotype are more predictive than geographic 
location. Med Pediatr Oncol. 1997;28:248–254.  
7. Miettinen M, Franssila KO, Saxen E. Hodgkin’s 
disease, lymphocytic predominance nodular. 
Increased risk for subsequent non-Hodgkin’s 
lymphomas. Cancer. 1983;51:2293–2300.  
8. Mokhtar N, Gouda I, Adel I. Cancer Pathology 
Registry Book (2003–2004) and Time Trend 
Analysis.1st ed. Cairo: NCI, Cairo University; 
2007. 
9. Tinguely M, Vonlanthen R, Müller E, et al. 
Hodgkin's disease-like lymphoproliferative 
disorders in patients with different underlying 
immunodeficiency states. Mod Pathol 1998; 
11:307. 
10. Glaser SL, Clarke CA, Gulley ML, et al. 
Population-based patterns of human 
immunodeficiency virus-related Hodgkin 
lymphoma in the Greater San Francisco Bay Area, 
1988-1998. Cancer 2003; 98:300. 
11. Garnier JL, Lebranchu Y, Dantal J, et al. 
Hodgkin's disease after transplantation. 
Transplantation 1996; 61:71. 
12. Patel P, Hanson DL, Sullivan PS, et al. Incidence 
of types of cancer among HIV-infected persons 
compared with the general population in the 
United States, 1992-2003. Ann Intern Med 2008; 
148:728. 
